Teleconsultation Approach to CTD-ILD Care Delivery in Rural UnderServed CommuniTies (TRUST Initiative)

Inclusion Criteria

• •1. Age: Adults aged 18 years or older.
• •2. Diagnosis and Stable Condition:
• •* Confirmed diagnosis of connective tissue disease-associated interstitial lung disease (CTD-ILD) by a physician based on clinical, radiographic, and/or pathological criteria. CTDs may include scleroderma, systemic lupus erythematosus, rheumatoid arthritis, mixed connective tissue disease, Sjogren's disease (primary or secondary), inflammatory myopathy including but not limited to dermatomyositis and polymyositis, or any overlap syndrome including one or more of these diseases.
• •* Diagnosis of CTD-ILD established at least one year prior to enrollment
• •3. Residence:
• •* Full time resident (at least six months per year) of one of the seven counties of the North Country region of New York (St. Lawrence, Franklin, Jefferson, Lewis, Hamilton, Clinton, Essex)
• •4. Active Care Relationship:
• •* Documented diagnosis of CTD-ILD via any of the following:
• •o SLH-affiliated clinician
• •o Historical records
• •* Determination by PI
• •* Or an active SLH medical record (≥1 clinical encounter, test, or treatment in past 24 months)
• •5. Pulmonary Function Testing and safety labs:
• •* Ability and willingness to perform pulmonary function and safety lab tests at local facilities as required by the study protocol.
• •* Most recent PFT within 24 months prior to baseline
• •6. Consent:
• •* Provide written informed consent to participate in the study, including consent for data collection and telehealth consultations.
• •8\. Contraception
• •\- Female patients of child-bearing potential (FOCBP) must use at least one highly effective method of contraception between weeks 0 and 48 of the study (complete abstinence, estrogen+progesterone oral contraceptive pill (OCP), progestin-only pill (POP), estrogen+progesterone patch, vaginal ring, Nexplanon, DepoProvera, IUD, bilateral tubal ligation, male partner vasectomy completed at least six months prior to Day 0).